LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.77 | 84.90 | 262 | 6252 | 0.0419 | 0.1992 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.77 | 84.90 | 2226 | 6252 | 0.3560 | 0.6932 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.77 | 84.90 | 2226 | 6252 | 0.3560 | 0.6932 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.77 | 84.90 | 2446 | 6252 | 0.3912 | 0.7192 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 84.90 | 283 | 6567 | 0.0431 | 0.2116 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 84.90 | 2317 | 6567 | 0.3528 | 0.6940 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 84.90 | 2355 | 6567 | 0.3586 | 0.6984 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 84.90 | 2563 | 6567 | 0.3902 | 0.7214 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.18 | 84.90 | 327 | 6963 | 0.0470 | 0.2363 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.18 | 84.90 | 2445 | 6963 | 0.3511 | 0.6964 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.18 | 84.90 | 2421 | 6963 | 0.3477 | 0.6938 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.18 | 84.90 | 2652 | 6963 | 0.3809 | 0.7183 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.88 | 84.90 | 323 | 7291 | 0.0443 | 0.2312 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.88 | 84.90 | 2494 | 7291 | 0.3420 | 0.6924 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.88 | 84.90 | 2502 | 7291 | 0.3431 | 0.6932 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.88 | 84.90 | 2772 | 7291 | 0.3802 | 0.7205 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 60.59 | 84.90 | 315 | 7641 | 0.0412 | 0.2238 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 60.59 | 84.90 | 2625 | 7641 | 0.3435 | 0.6965 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 60.59 | 84.90 | 2650 | 7641 | 0.3468 | 0.6990 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 60.59 | 84.90 | 2882 | 7641 | 0.3771 | 0.7211 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.29 | 84.90 | 356 | 7934 | 0.0449 | 0.2448 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.29 | 84.90 | 2742 | 7934 | 0.3456 | 0.7004 | MN20160318_Q02 | D16 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.29 | 84.90 | 2741 | 7934 | 0.3455 | 0.7003 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.29 | 84.90 | 2969 | 7934 | 0.3742 | 0.7211 | MN20160318_Q02 | K11 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 63.99 | 84.90 | 392 | 8212 | 0.0477 | 0.2610 | MN20160318_Q02 | D16 |